Only one step from tailored oncological therapies

Abstract

The personalization of oncological therapy is becoming a reality thanks to the development of molecular biology techniques (e.g. next generation sequencing, liquid biopsy) and the discovery of new molecularly targeted therapies and immunotherapeutics. Genetic laboratories and clinical centers, which form international networks as well as global, early phase clinical trials make it possible to match treatments to a particular patient. The benefit of such a procedure is currently difficult to estimate, but it seems that another path for the development of oncology is not possible.